Company Filing History:
Years Active: 2017
Title: Innovations by Christopher Ambri in Implantable Infusion Devices
Introduction
Christopher Ambri is an accomplished inventor based in Mesa, AZ (US). He has made significant contributions to the field of medical technology, particularly in the development of implantable infusion devices. With a total of 2 patents, his work focuses on enhancing the functionality and efficiency of these devices.
Latest Patents
Ambri's latest patents include innovative designs for implantable infusion devices. The first patent describes an implantable infusion device that features a voltage boost circuit and a selection circuit. This device is designed to alternately connect a battery with a charging circuit, ensuring that the pump is actuated effectively. The charging circuit supplies current to a charge storage unit from the battery, while the voltage boost circuit provides a boosted battery voltage. This design allows for improved energy management and device performance.
The second patent also pertains to an implantable infusion device, which includes a selective voltage boost circuit with a charge pump circuit. This device generates control signals using two different profiles to manage the output voltage. The charge pump circuit increases the output voltage in response to these control signals, allowing for precise control over the infusion process. This innovation enhances the adaptability and efficiency of the device in various medical applications.
Career Highlights
Christopher Ambri is currently employed at Medtronic, Inc., a leading company in medical technology. His work at Medtronic has allowed him to collaborate with other talented professionals in the field, contributing to advancements in healthcare technology.
Collaborations
Some of his notable coworkers include Charles Randall Rogers and Scott A Sarkinen. Their combined expertise has fostered a collaborative environment that drives innovation in medical devices.
Conclusion
Christopher Ambri's contributions to the field of implantable infusion devices demonstrate his commitment to advancing medical technology. His innovative patents reflect a deep understanding of the challenges in this area and a dedication to improving patient care.